Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
03/2012
03/21/2012CN102382189A Synthesis method of 5-hydroxymethylfurfural complete antigen
03/21/2012CN102382188A Method for preparing carperitide acetate
03/21/2012CN102382187A FBXL15 protein fragment, coding gene thereof, and application of FBXL15 protein fragment and coding gene
03/21/2012CN102382186A Antibacterial peptide GLI23 derived from linear chicken beta-phylaxin4 (RL38) and preparation method thereof
03/21/2012CN102382185A Plant aquaporin and application of encoding gene thereof
03/21/2012CN102382184A Plant resistance-related protein ATSAR19 and coding gene and application thereof
03/21/2012CN102382183A Method for extracting antibacterial peptide from orychophragmus violaceus
03/21/2012CN102382182A Protein NEK6 relevant to plant stress tolerance and coding genes of protein NEK6 and application
03/21/2012CN102382181A Method for extracting active proteins with antioxidant and hypoglycemic functions from mushrooms
03/21/2012CN102382180A Na+/H+reverse transfer protein Nha-K1, and encoding gene and application thereof
03/21/2012CN102382179A Peptide sequences and compositions
03/21/2012CN102382172A Binding agents which inhibit myostatin
03/21/2012CN102380097A Peptide-based passive immunization therapy for treatment of atherosclerosis
03/21/2012CN102380094A Application of specific polypeptide to preparation of rabies vaccine
03/21/2012CN102380091A Application of interleukin-22 in curing virus hepatitis
03/21/2012CN102380090A G-CSF (granulocyte-colony stimulating factor) dimmer applied to treat neutropenia
03/21/2012CN101805738B Peculiar p53 mutated protein-p53N236S of ALT tumor caused by progeria syndrome and application thereof
03/21/2012CN101704886B Human alpha-defensin 5 antiviral active mutant polypeptide and preparation method and application
03/21/2012CN101591386B Polypeptide capable of inhibiting excitable and toxic damages and use thereof
03/21/2012CN101555283B Antibodies to non-functional p2x7 receptor, diagnosis and treatment of cancers and other conditions
03/21/2012CN101548013B Gmrd22-like genes and use thereof to protect against abiotic stress
03/21/2012CN101503462B Method for removing endotoxin in influenza virus stock solution
03/21/2012CN101457226B Gene with nerve repair function, coding protein, interactive receptor and use thereof
03/21/2012CN101355963B Marked bovine viral diarrhea virus vaccines
03/21/2012CN101265288B Method for purifying CRM197 mutant
03/21/2012CN101177700B Methods and means for producing proteins with predetermined post-translational modifications
03/21/2012CN101168564B Human antibiotic peptide and use for derivative thereof
03/20/2012US8138393 Production of high tryptophan maize by chloroplast targeted expression of anthranilate synthase
03/20/2012US8138323 Cytokines; side effect reduction; bactericides; antitumor agents; anticarcinogenic agents
03/20/2012US8138322 Human T1R2 nucleic acid sequences and polypeptides
03/20/2012US8138312 Compositions for regulation of tumor necrosis factor-alpha
03/20/2012US8138311 Modified proteins, designer toxins, and methods of making thereof
03/20/2012US8138310 Chimeric CD154 polypeptides
03/20/2012US8138309 Modified rubisco large subunit n-methyltransferase useful for targeting molecules to the active-site vicinity of ribulose-1,5-bisphosphate
03/20/2012US8138307 Parkin interacting polypeptides and methods of use
03/20/2012US8138305 Glucagon-like peptide-1 (glp-1) receptor agonist; diabetes, obesity, glucagonomas, secretory disorders of the airway, metabolic disorder, arthritis, osteoporosis, central nervous system disease, restenosis and neurodegenerative disease.
03/20/2012US8138229 Compositions and methods of delivery of pharmacological agents
03/20/2012US8138155 Compounds for intracellular delivery of therapeutic moieties to nerve cells
03/20/2012US8138152 Methods of treatment using WISP polypeptides
03/20/2012US8138147 Conditioned cell culture medium compositions and methods of use
03/20/2012US8138146 Antiviral peptide and antiviral agent
03/20/2012US8138143 Methods for treating a neurological disorder by peripheral administration of a trophic factor
03/20/2012US8138140 Self-assembling peptide amphiphiles and related methods for growth factor delivery
03/20/2012US8138139 Use of RGD-enriched gelatine-like proteins for inhibition of cancer metastasis
03/20/2012US8137960 Bovine adeno-associated viral (BAAV) vector and uses thereof
03/20/2012US8137934 Regeneration and neogenesis of retinal photoreceptor cell using Otx2 gene
03/20/2012US8137931 Fusion proteins of HIV regulatory/accessory proteins
03/20/2012US8137927 Molded protein material in form of pellet for sensor
03/20/2012US8137924 Method and compositions for detecting botulinum neurotoxin
03/20/2012US8137923 Glycoprotein VI and uses thereof
03/20/2012US8137918 Sperm-specific cation channel, CatSper4, and uses therefor
03/20/2012US8137915 Genes involved in intestinal inflammatory diseases and use thereof
03/20/2012US8137914 Allelic fetal plasma protein for use as diagnostic/prognostic tool in detection of hematopoietic cell proliferative disorders
03/20/2012US8137675 Bont/a peptides and methodsof predicting and reducing immunoresistance to botulinum toxin therapy
03/20/2012US8137673 Nucleic acids and proteins from Streptococcus groups A & B
03/20/2012US8137662 Proliferated cell lines and uses thereof
03/20/2012CA2763795A1 Affinity-conjugated nucleoprotein-papaya mosaic virus-like particles and uses thereof
03/20/2012CA2654610C Insulinotropic peptide synthesis
03/20/2012CA2514507C Methods and compositions for the treatment of gastrointestinal disorders
03/20/2012CA2509484C Stabilized immunogenic hbc chimer particles
03/20/2012CA2505869C Live attenuated vaccine against porcine pleuropneumonia
03/20/2012CA2498167C Water-soluble polymer alkanals
03/20/2012CA2483547C Keratinocytes expressing exogenous angiogenic growth factors
03/20/2012CA2472477C Methods and compositions for protein expression and purification
03/20/2012CA2461823C Hiv and cd4 transgenic animals and uses therefor
03/20/2012CA2453300C Chimeric chains that code for proteins that induce effects directed against viruses
03/20/2012CA2429172C Novel mutant allergens
03/20/2012CA2426793C Bacillus thuringiensis proteins and variants thereof with pesticidal activity against coleopterans
03/20/2012CA2405469C Integrin binding peptide derivatives
03/20/2012CA2402210C Collagen membrane carrying therapeutic genetic material for tissue regeneration
03/20/2012CA2392453C Modulation of signal transduction
03/20/2012CA2379564C Structural protein of adeno-associated virus with modified chromatographic properties, its production and use
03/20/2012CA2363067C Compounds and methods to inhibit or augment an inflammatory response
03/20/2012CA2360107C Stress tolerant plants
03/20/2012CA2360020C Methods for differentiating and monitoring parathyroid and bone status related diseases
03/20/2012CA2352603C Gp120 mutants and biological applications
03/20/2012CA2348755C Polypeptide compositions toxic to diabrotica insects, obtained from bacillus thuringiensis; cryet70, and methods of use
03/20/2012CA2334857C Interferon inducing genetically engineered attenuated viruses
03/20/2012CA2304207C Rna export element and methods of use
03/20/2012CA2299560C Human defensin def-x, gene and dnac, composition containing same and diagnostic and therapeutic applications
03/20/2012CA2296842C Ligands, including antibodies, showing reactivity against endocrine cells
03/20/2012CA2222000C Abundant extracellular products and methods for their production and use
03/15/2012WO2012034070A1 Use of liposomal wnt compositions to enhance osseointegration
03/15/2012WO2012034067A1 Methods and compositions involving protective staphylococcal antigens
03/15/2012WO2012034025A2 Human cytomegalovirus vaccine
03/15/2012WO2012033870A1 Recombinant phycobiliproteins with enhanced fluorescence and photochemical properties
03/15/2012WO2012033181A1 Culture method and culture device
03/15/2012WO2012033154A1 Translation and construction of non-standard peptide compound library containing n-methyl amino acids and other non-standard amino acids, and method for searching for active species
03/15/2012WO2012033140A1 Chemical substance detection sensor and chemical substance detection method
03/15/2012WO2012032489A1 Non-lipidated variants of neisseria meningitidis orf2086 antigens
03/15/2012WO2012032348A1 Foot and mouth disease virus with increased stability and its use as vaccine
03/15/2012WO2012032287A2 Gene regulation
03/15/2012WO2012032112A1 Stem cell culture media and methods
03/15/2012WO2012032103A1 Mutant channelrhodopsin 2
03/15/2012WO2012032069A1 Recombinant bacterial lipocalin blc and uses thereof
03/15/2012WO2012032068A2 Compounds and methods
03/15/2012WO2012031878A1 A thaumatin-based improved sweetening composition and edible products made therewith
03/15/2012WO2012031760A1 Parvovirus mutated structural proteins comprising cross - protective b - cell epitopes of a hpv l2 protein as well as products and methods relating thereto
03/15/2012WO2012031744A1 Chimeric antigen receptors with an optimized hinge region
03/15/2012WO2012031530A1 Use of multi-target recombinant gene and protein thereof in the prevention or treatment of helicobacter pylori infection
1 ... 277 278 279 280 281 282 283 284 285 286 287 288 289 290 291 292 293 294 295 296 297 ... 2916